Recombinant Chicken Sodium/potassium-transporting ATPase subunit beta-3 (ATP1B3)

What is chicken ATP1B3 and what are its primary functions?

Chicken ATP1B3 (Sodium/potassium-transporting ATPase subunit beta-3) is a critical beta subunit of the Na+/K+-ATPase enzyme complex encoded by the ATP1B3 gene (GenBank accession NM_205535.1) . The protein belongs to the family of Na+/K+ and H+/K+ ATPases beta chain proteins, which function as plasma membrane pumps with diverse physiological roles . ATP1B3 is primarily responsible for the formation and structural integrity of the Na+/K+-ATPase holoenzyme, which establishes and maintains the electrochemical gradients of Na+ and K+ ions across the plasma membrane .

The primary functions of chicken ATP1B3 include:

• Contributing to osmoregulation mechanisms

• Supporting sodium-coupled transport of various organic and inorganic molecules

• Maintaining electrical excitability in nerve and muscle tissues

• Potentially participating in cell adhesion processes via its C-terminal immunoglobulin-like domain

Research has demonstrated that ATP1B3 plays additional roles in immune regulation by up-regulating lymphocyte activity and promoting the production of cytokines including IFN-γ, IL-2, IL-4, and IL-10, suggesting potential applications as a therapeutic target in viral infections .

How is the ATP1B3 gene characterized in chickens?

The chicken ATP1B3 gene spans 846 base pairs and encodes the beta-3 subunit of the Na+/K+-ATPase complex . While the human ATP1B3 gene is mapped to chromosome 3q23 with a pseudogene located on chromosome 2, the chicken gene has distinct genomic organization appropriate to avian species . The gene contains specific regulatory elements that control its expression in various tissues.

When amplifying the chicken ATP1B3 gene for research applications, specific primers have been designed and validated:

• Forward primer: 5′-ATGAGCAAGGAGACGAAGAAG-3′

• Reverse primer: 5′-TCACTATTCAGTCATCTCAACTTTGAAGGC-3′

For quantitative analysis of ATP1B3 expression, researchers have successfully utilized the following qRT-PCR primers:

• Forward primer: 5′-ATGAGCAAGGAGACGAAGAAGC-3′

• Reverse primer: 5′-CCGCGAGGAAGCCATAAAAT-3′

These primers produce an amplicon of 154 bp, making them suitable for real-time PCR applications in studying ATP1B3 expression patterns across different experimental conditions.

What are the established methods for cloning and expressing recombinant chicken ATP1B3?

The established protocol for cloning and expressing recombinant chicken ATP1B3 involves several critical steps:

• Source tissue selection: Chicken embryo kidney (CEK) cells have been successfully used as a source for ATP1B3 isolation . These cells are typically prepared from 20-day-old specific-pathogen-free (SPF) chicken embryos, with kidneys trypsinized at 37°C for 30 minutes.

• RNA extraction and cDNA synthesis: Total RNA is extracted using commercially available kits such as Ultrapure RNA Kit, followed by reverse transcription to obtain cDNA using appropriate reverse transcriptases .

• PCR amplification: The ATP1B3 gene is amplified using specific primers (as mentioned in section 1.2) with an annealing temperature of approximately 50°C .

• Cloning vector selection: For expression studies, ATP1B3 has been successfully cloned into various vectors including:

  • pDsRed for fluorescent protein fusion applications

  • pcDNA3.1-Myc for mammalian expression with epitope tagging

• Expression systems: Both HEK293T cells and avian cell lines (such as DF-1) have been documented as effective systems for recombinant chicken ATP1B3 expression .

For optimal expression, cells are typically cultured in appropriate media (DMEM supplemented with 10% FBS for HEK293T and DF-1 cells, or M199 medium with 5% FBS for CEK cells) at 37°C in a 5% CO₂ incubator .

What analytical techniques are most effective for studying ATP1B3 protein interactions?

Several analytical techniques have demonstrated efficacy in studying ATP1B3 protein interactions:

• Yeast Two-Hybrid (Y2H) System: This approach has been effectively used to screen for proteins that interact with various targets and could be applied to ATP1B3 studies . The system involves:

  • Construction of cDNA libraries from relevant tissues

  • Transformation into yeast strains

  • Selection on appropriate dropout media

  • Confirmation of positive interactions

• Co-Immunoprecipitation (Co-IP): This is a gold-standard technique for validating protein-protein interactions involving ATP1B3 . The protocol typically involves:

  • Co-transfection of cells with tagged ATP1B3 (e.g., pcDNA3.1-ATP1B3-Myc) and potential interaction partners

  • Cell lysis using appropriate buffers (e.g., RIPA buffer)

  • Immunoprecipitation using antibody-conjugated magnetic beads

  • Western blotting for detection of co-precipitated proteins

• Fluorescence microscopy: Utilizing tagged versions of ATP1B3 (such as ATP1B3-DsRed fusions) allows for visualization of subcellular localization and co-localization with potential interaction partners .

• Bioinformatic analysis: Tools such as STRING database and DAVID facilitate functional analysis of ATP1B3 interactions, including GO term enrichment and pathway analysis .

For validating the quality of interaction data, multiple complementary approaches are recommended, with Co-IP serving as the confirmatory technique after initial screening methods.

How is ATP1B3 expression regulated in different chicken tissues?

ATP1B3 expression varies across chicken tissues with distinct regulatory mechanisms:

• Tissue-specific expression patterns: While comprehensive chicken tissue expression atlases for ATP1B3 are still being developed, research indicates significant expression in kidney tissues, which has made them a preferred source for ATP1B3 isolation and study .

• Cell density-dependent regulation: Evidence suggests that the quantity of ATP1B3 in the plasma membrane is mediated by cell density . This regulatory mechanism implies potential roles in:

  • Contact inhibition processes

  • Cell-cell adhesion functions

  • Tissue architecture maintenance

• Transcriptional regulation: Analysis of the ATP1B3 promoter region reveals binding sites for several transcription factors, suggesting complex regulatory control that responds to various physiological and environmental signals.

• Post-translational modifications: The ATP1B3 protein undergoes several modifications that affect its stability, localization, and function, including glycosylation patterns that may vary across tissues.

When studying ATP1B3 expression, it is recommended to use qRT-PCR with the validated primers mentioned previously, with β-actin serving as an appropriate internal reference gene for standardization .

What factors influence the structural stability of recombinant ATP1B3 in experimental systems?

Several critical factors influence the structural stability of recombinant ATP1B3 in experimental systems:

• Expression system selection: Different expression systems (bacterial, insect, mammalian) produce variations in post-translational modifications that affect ATP1B3 stability. Mammalian expression systems like HEK293T cells provide more native-like modifications for optimal structural integrity .

• Buffer composition: The stability of purified ATP1B3 is significantly influenced by:

  • pH (optimal range typically 7.0-7.5)

  • Ionic strength (physiological salt concentrations)

  • Presence of stabilizing agents (glycerol, specific detergents for membrane proteins)

• Temperature considerations: ATP1B3, being a membrane-associated protein, is sensitive to temperature fluctuations during purification and storage. Maintaining samples at 4°C during processing and -80°C for long-term storage helps preserve structural integrity.

• Association with alpha subunits: Research indicates that beta subunits of Na+/K+-ATPase, including ATP1B3, achieve maximal stability when co-expressed with appropriate alpha subunits, as they form a functional heterodimeric complex in vivo.

• Detergent selection: For structural studies of ATP1B3, the choice of detergent is critical:

  • Mild non-ionic detergents (DDM, LMNG) better preserve native structure

  • Detergent concentration must be maintained above CMC (critical micelle concentration)

  • Detergent exchange may be necessary for different experimental applications

Monitoring protein stability through techniques such as thermal shift assays, limited proteolysis, and dynamic light scattering provides valuable data on optimal conditions for maintaining ATP1B3 structural integrity.

How does ATP1B3 contribute to viral infection mechanisms in avian systems?

ATP1B3 plays multifaceted roles in viral infection mechanisms in avian systems:

• Antiviral activity: Research demonstrates that ATP1B3 can repress Enterovirus 71 (EV71) replication by promoting the production of type-I interferons . Experimental evidence shows:

  • Knockdown of ATP1B3 enhances EV71 replication

  • Overexpression of ATP1B3 represses EV71 replication in susceptible cells

• Interactions with viral proteins: Studies have investigated ATP1B3 as a potential interaction partner with viral components, such as the non-structural protein 2 (Nsp2) of Infectious Bronchitis Virus (IBV) . These interactions may:

  • Facilitate or inhibit viral replication processes

  • Affect viral protein localization within infected cells

  • Modulate host immune responses

• Immune modulation: ATP1B3 up-regulates lymphocyte activity and promotes the production of multiple cytokines including IFN-γ, IL-2, IL-4, and IL-10 . This immune-modulatory capacity positions ATP1B3 as:

  • A potential regulator of host immune responses to viral infection

  • A mediator of inflammation during infection

  • A target for therapeutic intervention

• BST-2 regulation: ATP1B3 functions as a co-factor that accelerates BST-2 degradation, potentially reducing BST-2-mediated restriction of viral production and NF-κB activation . This mechanism has implications for:

  • HIV-1 infection models

  • Potentially other enveloped viruses in avian systems

  • Cellular innate immune responses

The complex role of ATP1B3 in viral infections positions it as both a potential therapeutic target and a marker for monitoring infection progression in avian systems.

What experimental approaches reveal ATP1B3 function in immune regulation?

Multiple experimental approaches have been employed to elucidate ATP1B3's role in immune regulation:

• Gene silencing techniques:

  • RNA interference (siRNA) targeting ATP1B3 has revealed its impact on immune response genes

  • When ATP1B3 is silenced, increased expression of BST-2 occurs on the cell surface, indicating ATP1B3's role in regulating this important immune mediator

• Overexpression studies:

  • Transfection with ATP1B3 expression constructs demonstrates effects on cytokine production

  • Standardized protocols utilize pcDNA3.1-based vectors with appropriate epitope tags for detection

• Cytokine profiling:

  • ELISA and multiplex cytokine assays quantify the impact of ATP1B3 manipulation on:

    • IFN-γ, IL-2, IL-4, and IL-10 production

    • Type-I interferon responses

    • Pro-inflammatory mediators

• Co-immunoprecipitation assays:

  • Co-IP using antibody-coupled magnetic beads reveals physical interactions between ATP1B3 and immune regulatory proteins

  • Standardized protocol includes:

    • Cell lysis with RIPA buffer

    • Overnight incubation with antibody-conjugated beads at 4°C

    • Thorough washing with TBST buffer

    • SDS-PAGE separation and Western blotting analysis

• Quantitative PCR analysis:

  • qRT-PCR using validated primers monitors expression changes in ATP1B3 and immune-related genes

  • The 2^(-ΔΔCT) method quantifies fold changes in mRNA expression

  • β-actin serves as an appropriate internal reference gene

These methodological approaches provide complementary data on ATP1B3's role in immune regulation, particularly in the context of viral infections in avian systems.

How can structural analysis of ATP1B3 inform therapeutic development?

Structural analysis of ATP1B3 provides critical insights for therapeutic development through multiple approaches:

• Immunoglobulin-like domain characterization: The C-terminal portion of ATP1B3 folds into an immunoglobulin-like domain that may mediate cell adhesion functions . Structural characterization of this domain through techniques such as X-ray crystallography or cryo-EM can reveal:

  • Binding interfaces for protein-protein interactions

  • Potential sites for targeted therapeutic intervention

  • Structural elements that contribute to immune regulation

• Interaction interface mapping: Molecular docking simulations combined with experimental validation can identify critical residues involved in:

  • ATP1B3 interaction with viral proteins

  • Association with immune regulatory molecules

  • Binding to alpha subunits in the Na+/K+-ATPase complex

• Post-translational modification sites: Identification of glycosylation, phosphorylation, and other modification sites through mass spectrometry informs:

  • Regions essential for protein stability

  • Regulatory mechanisms affecting ATP1B3 function

  • Potential targets for modulating ATP1B3 activity

• Structure-based drug design: High-resolution structural data enables:

  • Virtual screening of compound libraries against ATP1B3 binding sites

  • Fragment-based drug discovery approaches

  • Rational design of peptide-based inhibitors or activators

The C-terminal immunoglobulin-like domain of ATP1B3 is of particular interest due to its potential role in both cell adhesion and immune regulation, making it a promising target for therapeutic development in viral infections .

What are the emerging applications of ATP1B3 in avian disease models?

ATP1B3 shows promising applications in avian disease models through several emerging research directions:

• Viral infection therapeutic target: ATP1B3's ability to repress viral replication by promoting type-I interferons positions it as a potential therapeutic target in EV71 infection and potentially other viral diseases . Research approaches include:

  • Development of small molecules that enhance ATP1B3 activity

  • Gene therapy approaches to increase ATP1B3 expression

  • Peptide mimetics targeting ATP1B3-mediated pathways

• Biomarker development: Changes in ATP1B3 expression during disease progression could serve as biomarkers for:

  • Early detection of viral infections

  • Monitoring treatment efficacy

  • Predicting disease outcomes

• Infectious Bronchitis Virus (IBV) research: Studies have identified ATP1B3 as interacting with IBV Nsp2 protein, suggesting mechanisms through which IBV may manipulate host cell functions . This finding opens avenues for:

  • Understanding IBV pathogenesis

  • Developing targeted antiviral strategies

  • Identifying host factors essential for viral replication

• Pain modulation applications: Research indicates that mutations within ATP1B3 may connect with differences in pain behavior, specifically in formalin pain models . This suggests potential for:

  • Pain management approaches in avian veterinary medicine

  • Comparative studies between avian and mammalian pain mechanisms

  • Development of novel analgesic compounds

• Cell-cell adhesion research: ATP1B3's involvement in cell-cell adhesion, mediated by its immunoglobulin-like domain, suggests applications in:

  • Tissue engineering approaches

  • Regenerative medicine in avian systems

  • Understanding tissue architecture in health and disease

The diverse functions of ATP1B3 in viral defense, immune modulation, and cellular adhesion make it a versatile target for therapeutic development across multiple avian disease models.

What are the critical quality control measures for recombinant ATP1B3 production?

Ensuring high-quality recombinant ATP1B3 production requires rigorous quality control measures:

• Sequence verification: Following cloning, comprehensive sequence verification is essential to confirm:

  • Complete coding sequence integrity

  • Correct reading frame with fusion tags

  • Absence of unintended mutations

• Expression validation: Multiple complementary methods should confirm expression:

  • Western blotting with specific antibodies (anti-ATP1B3, anti-tag)

  • Mass spectrometry for protein identification

  • Functional assays specific to ATP1B3 activity

• Purity assessment: Recombinant ATP1B3 preparation quality should be evaluated by:

  • SDS-PAGE with Coomassie or silver staining (>90% purity recommended)

  • Size exclusion chromatography to detect aggregation

  • Endotoxin testing for preparations intended for in vivo use

• Functional verification: Activity assays specific to ATP1B3 function should include:

  • Association with alpha subunits

  • Membrane localization assessment

  • Na+/K+-ATPase activity measurement when in complex

• Stability monitoring: The stability of prepared ATP1B3 should be assessed through:

  • Accelerated stability studies at different temperatures

  • Freeze-thaw cycle tolerance

  • Long-term storage condition optimization

When working with chicken ATP1B3, particular attention should be paid to the C-terminal immunoglobulin-like domain integrity, as this region is critical for protein-protein interactions and potential cell adhesion functions .

How can researchers optimize experimental design for ATP1B3 knockout/knockdown studies?

Optimizing experimental design for ATP1B3 knockout/knockdown studies requires careful consideration of several factors:

• Knockdown approach selection:

  • siRNA: Effective for temporary ATP1B3 knockdown (50-70% reduction typically achieved)

  • shRNA: Suitable for stable knockdown models

  • CRISPR-Cas9: Preferred for complete knockout studies

• siRNA design guidelines for ATP1B3:

  • Target sequences should be 19-21 nucleotides long

  • Avoid sequences with >16-17 contiguous base pairs of homology to other genes

  • Design multiple siRNAs targeting different regions of ATP1B3 transcript

  • Include appropriate negative controls (non-targeting siRNA)

• Transfection optimization:

  • For CEK cells, TransIntro EL Transfection Reagent has proven effective

  • Optimal cell confluence at transfection: 50%

  • Recommended post-transfection analysis timepoints: 24, 36, and 48 hours

• Knockdown validation:

  • qRT-PCR using validated primers (see section 3.1)

  • Western blotting with specific antibodies

  • Functional assays to confirm physiological impact

• Rescue experiments:

  • Design rescue constructs with silent mutations in the siRNA target sequence

  • Co-transfect with siRNA to verify phenotype specificity

  • Include appropriate controls (empty vector)

• Data analysis recommendations:

  • Use the 2^(-ΔΔCT) method for qRT-PCR data analysis

  • Standardize transcript levels against β-actin as internal reference

  • Perform statistical analysis using appropriate software (e.g., GraphPad Prism)

  • Present data as mean ± standard deviation from at least three independent experiments

When studying viral interactions with ATP1B3, researchers should consider optimal timing of infection following knockdown, as demonstrated in studies using CEK cells infected with IBV following ATP1B3 manipulation .